PRM178Evaluation And Validation Of The Proact Measures For Cancer Patients And Informal Caregivers

Autor: Shilling, VM, Starkings, RM, Jenkins, VA, Fallowfield, LJ

Publikováno v: In Value in Health October-November 2017 20(9):A763-A763

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits.

Autor: Fallowfield LJ; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK., Catt SL; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK., May SF; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK., Matthews L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK., Shilling VM; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK., Simcock R; Sussex Cancer Centre Brighton and Sussex University Hospitals Trust, Brighton, UK., Westwell S; Sussex Cancer Centre Brighton and Sussex University Hospitals Trust, Brighton, UK., Jenkins VA; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, England, BN1 9RX, UK. val@sussex.ac.uk.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2017 Jan; Vol. 25 (1), pp. 237-244. Date of Electronic Publication: 2016 Sep 13.